High potency dopaminergic treatment of neurological impairment associated with brain injury

Details for Australian Patent Application No. 2004222307 (hide)

Owner Neurohealing Pharmaceuticals, Inc.

Inventors Gamzu, Elkan R.; Fridman, Esteban A.; Farber, Neal M.; Katzman, Daniel E.; Merello, Marcelo

Agent Davies Collison Cave

Pub. Number AU-B-2004222307

PCT Pub. Number WO2004/082630

Priority 60/455,405 17.03.03 US

Filing date 17 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 17 April 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/52 (2006.01)

A61N 1/08 (2006.01) Electrotherapy - Arrangements or circuits for monitoring, protecting, controlling or indicating

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/082630 Priority application(s): WO2004/082630

17 April 2008 Application Accepted

  Published as AU-B-2004222307

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222310-Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2

2004222306-Novel cyclosporins